Ginkgo Bioworks Announces Financial Performance for 2024 Ending Fourth Quarter Highlights Growth in Cell Engineering and Biosecurity Revenues Ginkgo Bioworks reports a promising financial performance for Q4 and the full year 2024, showcasing revenue growth in its Cell Engineering sector and strategic restructuring efforts.

Ginkgo Bioworks Announces Financial Performance for 2024 Ending Fourth Quarter Highlights Growth in Cell Engineering and Biosecurity Revenues #USA #Boston #Ginkgo_Bioworks #Cell_Engineering #Biosecurity

Ginkgo Bioworks Announces Exciting Details for the Upcoming 2025 Ferment Conference in Boston Ginkgo Bioworks reveals its plans for the 2025 Ferment Conference series, featuring innovative biology advancements and expert discussions in Boston.

Ginkgo Bioworks Announces Exciting Details for the Upcoming 2025 Ferment Conference in Boston #USA #Boston #Ginkgo_Bioworks #Ferment_Conference #Cell_Engineering